SCHEMBL6765784

SCHEMBL6765784

CS(=O)(=O)NCCc1ccc2cc(OCCNC(=O)c3ccccc3)ccc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.63
NPC1 O15118 10/20 0.63
SMN1; SMN2 Q16637 5/20 0.63
HPGD P15428 1/20 0.53
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
MAPT P10636 2/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
F10 P00742 1/20 0.49
ALOX5 P09917 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
POLB P06746 1/20 0.46
CASP3 P42574 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6759300 0.85 ALDH1A1 (0.54) RAB9ANPC1SMN1; SMN2MTNR1AMTNR1B
SCHEMBL6763704 0.84 ALDH1A1 (0.51) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL6759313 0.82 MTNR1A (0.48) SMN1; SMN2HPGDKMT2AMAPTMTNR1A
SCHEMBL6763749 0.81 PPARG (0.63) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL6762092 0.81 HTT (0.66) SMN1; SMN2MEN1KMT2ACA1CA2
SCHEMBL6763717 0.79 ALDH1A1 (0.44) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL6571967 0.78 PTGS2 (0.45) SMN1; SMN2MEN1KMT2ACA1CA2
SCHEMBL6763745 0.77 GRIA4 (0.48) SMN1; SMN2MEN1KMT2ACA1CA2
SCHEMBL6763747 0.77 ALDH1A1 (0.47) SMN1; SMN2HPGDMEN1KMT2A
SCHEMBL6761044 0.76 ALDH1A1 (0.49) MEN1KMT2AALOX5MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147612-A1 Sulfonamide derivatives DAVISON JOSHUA ZWICK (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147612-A1 Sulfonamide derivatives GRIN1, GRIN2A, GRIA1 RAB9A 2451/4885NPC1 2223/4885SMN1; SMN2 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.